News

RM Catalyst consortium reports reveal Australia’s potential

The RM Catalyst consortium recently published two reports revealing Australia's potential to become a global…

Cell TherapiesNovember 11, 2021

News

Announcement from the Chair of the Cell Therapies Board

The Board of Directors of Cell Therapies Pty Ltd is delighted to announce that Ms. Michelle…

Cell TherapiesOctober 13, 2021

News

Protecting your cell therapy trial by building resilience in your supply chain

Supply chain complexity has always been a factor in healthcare. Drugs are often time- or…

Cell TherapiesSeptember 7, 2021

News

The fast path to first-in-human cell therapy trials

The development of cell and gene therapies (CGT) holds enormous promise for treating many different…

Cell TherapiesSeptember 6, 2021

News

Cell Therapies Pty Ltd facility accredited by the Ministry of Health, Labour and Welfare in Japan

Cell Therapies Pty Ltd, a leading provider of cell and gene therapy products in the…

Cell TherapiesJune 21, 2021

News

ISO certifications accredited to Cell Therapies Pty Ltd management systems

Cell Therapies Pty Ltd, a leading provider of cell and gene therapy products in the…

Cell TherapiesApril 30, 2021

News

Mr Peter Giannopoulos appointed as CEO of Cell Therapies Pty Ltd

Cell Therapies Pty Ltd, a leading provider of cell and gene therapy products in the…

Cell TherapiesApril 6, 2021

News

“INDUSTRY OF THE FUTURE”: A/Prof Dominic Wall talks onshore CAR-T manufacturing at Parliament House in Canberra

Cell Therapies Pty Ltd interim CEO and Chief Scientific Officer A/Prof Dominic Wall has spoken…

Cell TherapiesMarch 5, 2021

News

VIDEO: Novartis and Cell Therapies CAR-T Manufacturing Announcement

Last week we announced the TGA approval for Cell Therapies to manufacture Novartis’ CAR-T therapy,…

Cell TherapiesFebruary 18, 2021

News

TGA approves Cell Therapies Pty Ltd as the first Australian commercial CAR-T manufacturing site

Cell Therapies Pty Ltd, a contract manufacturing organisation located within the Peter MacCallum Cancer Centre,…

Cell TherapiesFebruary 11, 2021

News

Dr. Dawn Driscoll stepping down as Cell Therapies CEO

The Board of Cell Therapies Pty Ltd (CTPL) has announced that Dr Dawn Driscoll will…

Cell TherapiesNovember 11, 2020

News

Better Diagnostic Technologies for Cancer Detection

Cell tracking case study “Better diagnostic technologies for cancer detection” has been published on the…

Cell TherapiesOctober 21, 2020

Filter

Cell Therapies and Teijin Announce Strategic Collaboration to Expand Access to Advanced Cell and Gene Therapies in Japan and the Asia Pacific Region

Cell Therapies and Viral Vector Manufacturing Facility (VVMF) enters strategic collaboration

CTPL sign MoU with Xellera to Fast-Track CGT Access across APAC

News

RM Catalyst consortium reports reveal Australia’s potential

Announcement from the Chair of the Cell Therapies Board

Protecting your cell therapy trial by building resilience in your supply chain

The fast path to first-in-human cell therapy trials

Cell Therapies Pty Ltd facility accredited by the Ministry of Health, Labour and Welfare in Japan

ISO certifications accredited to Cell Therapies Pty Ltd management systems

Mr Peter Giannopoulos appointed as CEO of Cell Therapies Pty Ltd

“INDUSTRY OF THE FUTURE”: A/Prof Dominic Wall talks onshore CAR-T manufacturing at Parliament House in Canberra

VIDEO: Novartis and Cell Therapies CAR-T Manufacturing Announcement

TGA approves Cell Therapies Pty Ltd as the first Australian commercial CAR-T manufacturing site

Dr. Dawn Driscoll stepping down as Cell Therapies CEO

Better Diagnostic Technologies for Cancer Detection

Unrivalled experience and service from a global leader in cell and gene therapy manufacturing

Services

Helpful Links

Corporate